Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zuojin Wan Combined With Rabeprazole or Mosapride for the Treatment of Functional Dyspepsia Combined With Depression
Sponsor: Nanjing First Hospital, Nanjing Medical University
Summary
To evaluate the symptom improvement of Zuojinwan combined with rabeprazole or Zuojinwan combined with a mosapride regimen in patients with functional dyspepsia combined with depression (liver-stomach depression-heat type) using rabeprazole or mosapride regimen as a control, and to compare the patients' adherence to the medication and the adverse effects between the two groups.
Official title: A Single-centre Randomised Controlled Study of 4-week Zuojin Pills in Combination With Sodium Rabeprazole Enteric-coated Tablets or Mosapride Citrate for the Treatment of Functional Dyspepsia Combined With Depression
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2024-06-30
Completion Date
2025-04-30
Last Updated
2024-07-01
Healthy Volunteers
No
Conditions
Interventions
zuojinwan
In the Chinese medicine combination group, 3g of Zuojinwan was added to the western medicine group twice a day for 4 weeks.
Rabeprazole sodium enteric-coated tablets
For epigastric pain syndrome
mosapride citrate
Postprandial discomfort syndrome